Smart bandages--a colourful approach to early stage infection detection & control in wound care.

With the recent increase in bacterial resistance to conventional antibiotics, the early-stage detection and control of infection has become imperative in the fight against opportunistic pathogens in healthcare. The traditional β-lactam wonder-drugs (e.g. penicillin and cephalosporins), are rendered inactive due to enzymatic hydrolysis by bacterial β-lactamase enzymes as a bacterial defence mechanism. However, this deactivation mechanism produces different responses in the two aforementioned drugs - with the cephalosporins showing a molecular rearrangement mechanism which could be utilised for prodrug delivery. This unique mechanism could mean that inactive forms of cephalosporin antibiotics, once used as chemotherapeutics in oncology, could once again be used in the fight against disease as sensors to detect and treat bacterial colonisation. Therefore, we hypothesize that cephalosporin-dye bandages might provide an effective method to visually detect, and subsequently control, the early stages of an infection using photoantimicrobial chemotherapy (PACT).

[1]  J. Larrick,et al.  Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug , 2001, BMC chemical biology.

[2]  M. Wainwright Phenothiazinium photosensitisers: V. Photobactericidal activities of chromophore-methylated phenothiazinium salts , 2007 .

[3]  M. Wainwright,et al.  The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus. , 2003, FEMS immunology and medical microbiology.

[4]  A. Alanis,et al.  Resistance to antibiotics: are we in the post-antibiotic era? , 2005, Archives of medical research.

[5]  S. Hugonnet,et al.  Effectiveness of a hospital-wide programme to improve compliance with hand hygiene , 2000, The Lancet.

[6]  R. Bonomo,et al.  Three Decades of β-Lactamase Inhibitors , 2010, Clinical Microbiology Reviews.

[7]  M. Wainwright,et al.  Phenothiazinium photosensitisers VII: novel substituted asymmetric N-benzylphenothiaziniums as photoantimicrobial agents. , 2010, Journal of Photochemistry and Photobiology. B: Biology.

[8]  I. Wiegand,et al.  Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with Hypermutation , 2007, Antimicrobial Agents and Chemotherapy.

[9]  Edward Turos,et al.  Beta-lactams and their potential use as novel anticancer chemotherapeutics drugs. , 2004, Frontiers in bioscience : a journal and virtual library.

[10]  H. Humphreys,et al.  Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. , 2006, The Journal of hospital infection.

[11]  M. Wainwright Therapeutic applications of near‐infrared dyes , 2010 .

[12]  M. Wainwright,et al.  Photodynamic antimicrobial chemotherapy (PACT). , 1998, The Journal of antimicrobial chemotherapy.

[13]  M. Steed,et al.  Ceftaroline: A New Cephalosporin with Activity Against Resistant Gram‐Positive Pathogens , 2010, Pharmacotherapy.

[14]  M. Wainwright,et al.  Phenothiazinium photosensitisers, Part VI: Photobactericidal asymmetric derivatives , 2009 .

[15]  G L French,et al.  The continuing crisis in antibiotic resistance. , 2010, International journal of antimicrobial agents.

[16]  Carla Renata Arciola,et al.  Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. , 2010, Biomaterials.

[17]  L. Amaral,et al.  Review: The phenothiazinium chromophore and the evolution of antimalarial drugs , 2005, Tropical medicine & international health : TM & IH.

[18]  F. Koontz Trends in post-operative infections by Gram-positive bacteria. , 2000, International journal of antimicrobial agents.

[19]  D. G. Armstrong,et al.  Wound Microbiology and Associated Approaches to Wound Management , 2001, Clinical Microbiology Reviews.

[20]  G. Bignardi,et al.  MRSA screening: throat swabs are better than nose swabs. , 2009, The Journal of hospital infection.

[21]  Fred C Tenover,et al.  Mechanisms of antimicrobial resistance in bacteria. , 2006, The American journal of medicine.